Top-line data from the EVOGUARD clinical trial examining the efficacy of Phexxi for the prevention of chlamydia and gonorrhea are expected in October 2022.
New data showed a sharp drop in HIV tests administered in health care and non-health care settings from 2019 to 2020—primarily among persons disproportionately affected by HIV.
SAMPLE: Between 2019 and 2020, the rate of reported gonorrhea increased 10%. True or false? Plus, 6 more questions based on the CDC’s 2020 STD Surveillance Report.
Cases of gonorrhea, syphilis, and congenital syphilis in 2020 surpassed 2019 levels in the US, according to the CDC's 2020 STD Surveillance Report.
New study suggests HIV-1 infection is more virulent when transmitted through heterosexual penile-vaginal intercourse than through anal intercourse between men who have sex with men due to transmission bottlenecks.
The CDC update recommends that clinicians advise all sexually active patients about PrEP and includes a new section on prescribing injectable bimonthly cabotegravir.
California on Jan 1 became the first state to require insurance coverage for at-home testing for sexually transmitted infections; it isn't smooth sailing, yet.
The AAP updated its guidance to recommend routine HIV screening at least once in all adolescents aged ≥15 years and at-risk youth be rescreened annually.
Nearly 25% of patients with HIV who use antiretroviral therapy will reach 65 years of age or older by 2030, researchers projected in a new analysis.
The CDC released the first set of new STI guidelines since 2015. What are the notable updates that primary care physicians should know? Find out here.